OR YAT SUN (Sr. VP & CSO) received a stock award from ENANTA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/13/2026ACC: 0002064832-26-000008
Officer· Sr. VP & CSO
Since Nov 2018
+3.46K
Net shares
Net buyer
$48.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
6.88K acquired · 3.41K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+1.65K
Price / share
—
Trade value
—
% of position
0.4%
2/12/2026
371.39K→373.04K
Common Stock
Direct
Shares
+5.22K
Price / share
—
Trade value
—
% of position
1.4%
2/12/2026
373.04K→378.27K
Common Stock
Direct
Shares
−3.41K
Price / share
$14.25
Trade value
$48.64K
% of position
0.9%
2/12/2026
378.27K→374.85K
Total
Net shares
+3.46K
Net value
-$48.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | A · Award | +1.65K | — | — | 0.4% | 371.39K | 373.04K |
| Common Stock Direct | 2/12/2026 | A · Award | +5.22K | — | — | 1.4% | 373.04K | 378.27K |
| Common Stock Direct | 2/12/2026 | F · Tax Withholding | −3.41K | $14.25 | $48.64K | 0.9% | 378.27K | 374.85K |
| Total | +3.46K | -$48.64K | ||||||
Derivative Transactions0
No derivative transactions reported